The US oncology information system market is estimated to grow at a CAGR of 7.8% during the forecast period to reach nearly $1.3 billion in 2025 from $800 million in 2018. The US has a well-developed healthcare infrastructure with a considerable focus on patient health management. With the increasing prevalence of chronic diseases, the US healthcare providers primarily focus on providing better patient care. Therefore, a multidisciplinary approach is used in the US healthcare facilities in which a healthcare team is assembled from across the hospital. The shift towards a multidisciplinary approach leads to the adoption of advanced information systems among healthcare providers to support providing coordinated care to the patients. 

This approach has a significant role in cancer treatment owing to the increasing complexity of treatment, that contributes to the demand for advanced computing power to manage patient data for medical safety purpose. With the rising cancer incidences, healthcare providers are shifting their focus towards advanced information systems to manage patients’ database. As per the WHO, in 2018, the number of new cancer incidences reported was nearly 2.1 million, of which the number of cases in males and females was nearly 1.1 million and 981,867, respectively.

The US Oncology Information System market is segmented on the basis of oncology type and end-user. On the basis of oncology type, the market is segmented into medical oncology, radiation oncology, and surgical oncology. Medical oncology segment dominated the market in 2018 and is further estimated to continue the same trend over the forecast period. Medical oncology includes immunotherapy, chemotherapy, targeted therapy, and hormonal therapy. With the increasing number of cancer cases, the use of these therapies increases, which in turn, drives the segmental growth of the market. 

In addition, the key players such as Elekta AB, Verian Medical Systems, Inc., and Cerner Corp., contribute significantly to the segmental growth of the market. For instance, MOSAIQ Medical Oncology system offered by Elekta AB efficiently manage all the chemotherapy program, ranging from diagnosis to treatment post-follow-up. Additionally, it manages medical record of patient for multiple treatment types and reduces errors and inefficiencies. Furthermore, based on the end-user, the market is classified into hospitals and clinics, diagnostic centers, and others. 

The US Oncology Information System market is characterized with the presence of various players operating in the market. Some of the prominent players that contribute significantly in the market include Elekta AB, Cerner Corp., Koninklijke Philips N.V., Verian Medical Systems, Inc., Mckesson Corp., IBM Corp. and others. These players operate in very highly competitive environment and thus adopts various strategies to stay competitive in the market. Mergers and acquisitions, new product launch, geographical expansion, manufacturing capability expansion are some of the majorly adopted strategies by these market players. For instance, in July 2018, AdvancedMD, Inc. acquired Marietta, Georgia-based Nuesoft Technologies “NueMD”, a SaaS platform providing practice management, clinical and medical billing applications to simplify all aspects of running an independent practice. This acquisition was done to increase the company’s geographical presence in North America.  

Research Methodology

The market study of the US Oncology Information System market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Authenticate databases 
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. US Oncology Information System Market Research and Analysis by Oncology Type
2. US Oncology Information System Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of US Oncology Information System market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting US Oncology Information System market.
• Insights about market determinants that are stimulating US Oncology Information System market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.